Search PDMR transactions

Notifier
Name of person with notification obligation
Andreas Gerward
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Andreas Gerward
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Stayble Therapeutics AB
Issuer´s LEI code
549300WD23DE1US21868
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Stayble Therapeutics AB BTA SE0019912874 Subscription 40,000 Quantity 1.78 SEK 12/04/2023 Outside a trading venue
Subscription right/Unit right Stayble Therapeutics AB TR SE0019912866 Exercise decrease 28,000 Quantity 0.00 SEK 12/04/2023 Outside a trading venue
Subscription right/Unit right Stayble Therapeutics AB TR SE0019912866 Exercise decrease 250,599 Quantity 0.00 SEK 12/04/2023 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Stayble Therapeutics AB BTA SE0019912874 Subscription 12/04/2023 Outside a trading venue 40,000 (Quantity) 1.78 SEK
Stayble Therapeutics AB TR SE0019912866 Exercise decrease 12/04/2023 Outside a trading venue 278,599 (Quantity) 0.00 SEK
<< Back